Nintedanib for progressive fibrosing interstitial lung disease: how many meet criteria in a UK district general hospital systemic sclerosis cohort?

ABSTRACT:

SUBMITTER: Ho GN 

PROVIDER: S-EPMC10097451 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature